Ivermectin to Control Malaria - A Cluster-Randomized Trial.

Area of Science:

• Tropical Medicine
• Infectious Disease Epidemiology
• Clinical Pharmacology

Background:

• Insecticide resistance and vector adaptation threaten malaria control and elimination efforts.
• The potential of mass drug administration with ivermectin to reduce malaria transmission remains largely unexplored.

Purpose of the Study:

• To evaluate the efficacy of mass ivermectin administration in reducing malaria infection incidence.
• To assess the safety of mass ivermectin administration in a highly endemic region.

Main Methods:

• A cluster-randomized trial was conducted in Kwale, Kenya, comparing ivermectin to albendazole.
• Monthly mass drug administration for three months was administered to participants aged 5-15.
• Malaria infection incidence and adverse events were monitored for six months post-treatment.

Main Results:

• Ivermectin administration resulted in a 26% reduction in malaria infection incidence compared to albendazole.
• The adjusted incidence rate ratio for malaria infection was 0.74 (95% CI, 0.58 to 0.95; P=0.02).
• No significant difference in the incidence of serious adverse events was observed between groups.

Conclusions:

• Mass ivermectin administration, when combined with high bed net coverage, significantly lowers malaria infection rates in children.
• The study supports ivermectin as a safe and effective intervention for malaria control in endemic areas.